D

Duly Health and Care | 2614 W. Jefferson Street

Research site
(Unclaimed)
Location
2614 W. Jefferson Street, Joliet, Illinois, United States of America
Site insights

Top conditions

Breast Cancer (2 trials)

Triple Negative Breast Cancer (1 trial)

Small Cell Lung Carcinoma (1 trial)

Lung Cancer (1 trial)

Top treatments

Estrogen
Trilaciclib
Lurbinectedin
Topotecan
Sacituzumab
Everolimus
Irinotecan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the phy...

Enrolling
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Drug: Dexamethasone Mouth Rinse
Drug: LHRH Agonist

Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate and compare the activity and safety of two experimental arms con...

Enrolling
Relapsed Small Cell Lung Cancer
Drug: Irinotecan
Drug: Lurbinectedin

This is a Phase 2, multicenter, open-label, single arm study evaluating the safety and efficacy of trilaciclib administered prior to sacituzumab govi...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Sacituzumab Govitecan-hziy
Drug: Trilaciclib

Trial sponsors

G

G1 Therapeutics (1 trial)

Genentech logo

Genentech (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems